Agios Pharmaceuticals: Truist Securities cuts target price to $37 from $39
AGIO•Truist Securities cut its target price for Agios Pharmaceuticals to $37 from $39.
Related News
Ellington Credit declares monthly common distribution of $0.08 a share
EARN•
FICO survey shows 5.2% of tech leaders confident explaining AI decisions
FICO•
Citi upgrades XPO to 'buy' on share gains, pricing strength
XPO•
H&P and ExxonMobil expand deployment of FlexRobotics technology
HP•
Natera enrolls first patients in Signatera-guided melanoma trial evaluating early immunotherapy escalation
NTRA•